A small population of CD133+ cells in HCC cell lines and in primary HCC tissues mediates the high tumorigenicity and clonogenicity of HCC and upregulates the expression of multiple drug resistance-related genes [3]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.